Combination Treatment of C16 Peptide and Angiopoietin-1 Alleviates Neuromyelitis Optica in an Experimental Model

Mast cells in neuroinflammation and brain disorders

(2017) Erik Hendriksen et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Angiopoietin-1 and C16 Peptide Attenuate Vascular and Inflammatory Responses in Experimental Allergic Encephalomyelitis

(2016) Beibei Wang et al.   CNS & Neurological Disorders-Drug Targets

Role of C16, angiopoietin-1 and regeneration gene protein 2 in attenuating inflammation in an experimental rat model of autoimmune encephalomyelitis

(2016) Ke-Wei Tian et al.   JOURNAL OF ANATOMY

Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid

(2016) R. Marignier et al.   Journal of Neuroinflammation

Expression of the Astrocyte Water Channel Aquaporin-4 in the Mouse Brain

(2015) Jacqueline A. Hubbard et al.   ASN Neuro

The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model

(2015) Christian Geis et al.   EXPERIMENTAL NEUROLOGY

Experimental models of neuromyelitis optica: current status, challenges and future directions

(2015) Minshu Li et al.   Neuroscience Bulletin

Angiopoietin-1 ameliorates inflammation-induced vascular leakage and improves functional impairment in a rat model of acute experimental autoimmune encephalomyelitis

(2014) Hong Jiang et al.   EXPERIMENTAL NEUROLOGY

Functional Consequences of Neuromyelitis Optica-IgG Astrocyte Interactions on Blood-Brain Barrier Permeability and Granulocyte Recruitment

(2014) T. Vincent et al.   JOURNAL OF IMMUNOLOGY

An ανβ3 Integrin-Binding Peptide Ameliorates Symptoms of Chronic Progressive Experimental Autoimmune Encephalomyelitis by Alleviating Neuroinflammatory Responses in Mice

(2014) Fan Zhang et al.   Journal of Neuroimmune Pharmacology

Experimental mouse model of optic neuritis with inflammatory demyelination produced by passive transfer of neuromyelitis optica-immunoglobulin G

(2014) Nithi Asavapanumas et al.   Journal of Neuroinflammation

Overlapping CNS inflammatory diseases: differentiating features of NMO and MS

(2014) Maciej Juryńczyk et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Treatment of neuromyelitis optica: state-of-the-art and emerging therapies

(2014) Marios C. Papadopoulos et al.   Nature Reviews Neurology

Angiopoietin-1 peptide QHREDGS promotes osteoblast differentiation, bone matrix deposition and mineralization on biomedical materials

(2014) Nicole T. Feric et al.   Biomaterials Science

Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury

(2014) Nithi Asavapanumas et al.   Acta Neuropathologica Communications

Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica

(2013) Julien Ratelade et al.   ACTA NEUROPATHOLOGICA

Sera from patients with seropositive neuromyelitis optica spectral disorders caused the degeneration of rodent optic nerve

(2013) Yoshiko Matsumoto et al.   EXPERIMENTAL EYE RESEARCH

Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica

(2013) Hua Zhang et al.   JOURNAL OF CLINICAL INVESTIGATION

Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)

(2013) Corinna Trebst et al.   JOURNAL OF NEUROLOGY

Dose-Dependent Anti-Inflammatory and Neuroprotective Effects of anανβ3 Integrin-Binding Peptide

(2013) Shu Han et al.   MEDIATORS OF INFLAMMATION

C16 peptide shown to prevent leukocyte infiltration and alleviate detrimental inflammation in acute allergic encephalomyelitis model

(2013) Marong Fang et al.   NEUROPHARMACOLOGY

Antineuroinflammatory and neurotrophic effects of CNTF and C16 peptide in an acute experimental autoimmune encephalomyelitis rat model

(2013) Marong Fang et al.   Frontiers in Neuroanatomy

Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica

(2012) Ingo Kleiter   ARCHIVES OF NEUROLOGY

Treatment of neuromyelitis optica: an evidence based review

(2012) Douglas Sato et al.   ARQUIVOS DE NEURO-PSIQUIATRIA

Molecular Pathogenesis of Neuromyelitis Optica

(2012) Wajih Bukhari et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Vascular Disruption and the Role of Angiogenic Proteins After Spinal Cord Injury

(2011) Michelle T. L. Ng et al.   Translational Stroke Research

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice

(2010) Samira Saadoun et al.   BRAIN

Rescuing vasculature with intravenous angiopoietin-1 and  v 3 integrin peptide is protective after spinal cord injury

(2010) S. Han et al.   BRAIN

Photocrosslinkable chitosan modified with angiopoietin-1 peptide, QHREDGS, promotes survival of neonatal rat heart cells

(2010) Fiona Rask et al.   JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A

αVβ3 integrin regulates macrophage inflammatory responses via PI3 kinase/Akt-dependent NF-κB activation

(2010) Alexander S. Antonov et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Cutting Edge: Natalizumab Blocks Adhesion but Not Initial Contact of Human T Cells to the Blood-Brain Barrier In Vivo in an Animal Model of Multiple Sclerosis

(2009) Caroline Coisne et al.   JOURNAL OF IMMUNOLOGY

Neuromyelitis optica pathogenesis and aquaporin 4

(2008) David J Graber et al.   Journal of Neuroinflammation